New Key Statistics Module, Z-Score and F-Score
NYSE:HAE Key Ratios
Market Cap $ M | 3,850.66 |
Enterprise Value $ M | 4,776.34 |
P/E(ttm) | 31.81 |
PE Ratio without NRI | 24.03 |
Forward PE Ratio | 14.53 |
Price/Book | 4.40 |
Price/Sales | 2.90 |
Price/Free Cash Flow | 190.72 |
Price/Owner Earnings | 824.41 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 1,361.00 |
EPS (TTM) $ | 2.41 |
Beneish M-Score | -2.21 |
10-y EBITDA Growth Rate % | 12.10 |
5-y EBITDA Growth Rate % | 6.50 |
y-y EBITDA Growth Rate % | 5.90 |
EV-to-EBIT | 28.54 |
EV-to-EBITDA | 17.25 |
PEG | 3.70 |
Shares Outstanding M | 50.22 |
Net Margin (%) | 9.10 |
Operating Margin % | 12.15 |
Pre-tax Margin (%) | 11.67 |
Quick Ratio | 2.09 |
Current Ratio | 3.49 |
ROA % (ttm) | 5.40 |
ROE % (ttm) | 13.51 |
ROIC % (ttm) | 6.80 |
Dividend Yield % | -- |
Altman Z-Score | 2.70 |
HAE Number of Guru Trades
HAE Volume of Guru Trades
Gurus Latest Trades with NYSE:HAE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:HAE is held by these investors
Total 3
Haemonetics Corp Insider Transactions
No Available Data
News about NYSE:HAE
Total 0- 1